Danish phase II trial using adipose tissue derived mesenchymal stromal cells for patients with ischaemic heart failure

Danish phase II trial using adipose tissue derived mesenchymal stromal cells for patients with ischaemic heart failure

Abstract Aims Patients suffering from chronic ischaemic heart failure with reduced left ventricular ejection fraction (HFrEF) have reduced quality‐of‐life, repetitive hospital admissions, and reduced life expectancy. Allogeneic cell therapy is currently investigated as a potential treatment option a...

Full description

Bibliographic Details
Main Authors: Abbas Ali Qayyum, Mette Mouridsen, Brian Nilsson, Ida Gustafsson, Morten Schou, Olav Wendelboe Nielsen, Jens Dahlgaard Hove, Anders Bruun Mathiasen, Erik Jørgensen, Steffen Helqvist, Francis Richard Joshi, Ellen Mønsted Johansen, Bjarke Follin, Morten Juhl, Lisbeth Drozd Højgaard, Mandana Haack‐Sørensen, Annette Ekblond, Jens Kastrup
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:ESC Heart Failure
Subjects:
Adipose tissue derived mesenchymal stromal cells
Allogeneic cell therapy
Heart failure
Ischaemic heart disease
Stem cell
Randomized clinical trial
Online Access:https://doi.org/10.1002/ehf2.14281

Internet

https://doi.org/10.1002/ehf2.14281

Similar Items